Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.

Friedman DJ, Bhatt N, Hayman NS, Nichols BJ, Herman M, Nikolaev N, Danziger J.

Clin Endocrinol (Oxf). 2012 Jul;77(1):56-61. doi: 10.1111/j.1365-2265.2011.04229.x.

2.

Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season.

Alemzadeh R, Kichler J, Babar G, Calhoun M.

Metabolism. 2008 Feb;57(2):183-91. doi: 10.1016/j.metabol.2007.08.023.

PMID:
18191047
3.

Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3.

Stefíková K, Spustová V, Krivošíková Z, Okša A, Gazdíková K, Fedelešová V, Dzúrik R.

Physiol Res. 2011;60(1):149-55.

4.

Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.

Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR.

Hemodial Int. 2007 Jul;11(3):315-21.

PMID:
17576296
5.

Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents.

Alemzadeh R, Kichler J.

Metab Syndr Relat Disord. 2012 Dec;10(6):422-9. doi: 10.1089/met.2012.0056.

PMID:
22849753
6.

Vitamin D status is a determinant of skeletal muscle mass in obesity according to body fat percentage.

Shantavasinkul PC, Phanachet P, Puchaiwattananon O, Chailurkit LO, Lepananon T, Chanprasertyotin S, Ongphiphadhanakul B, Warodomwichit D.

Nutrition. 2015 Jun;31(6):801-6. doi: 10.1016/j.nut.2014.11.011.

PMID:
25933486
7.

Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile.

Stokić E, Kupusinac A, Tomić-Naglić D, Zavišić BK, Mitrović M, Smiljenić D, Soskić S, Isenović E.

Angiology. 2015 Mar;66(3):237-43. doi: 10.1177/0003319714528569.

PMID:
24658164
8.

Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females.

Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL.

Obesity (Silver Spring). 2011 Nov;19(11):2214-21. doi: 10.1038/oby.2011.110.

9.

Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus.

Sabio JM, Vargas-Hitos JA, Martinez-Bordonado J, Navarrete-Navarrete N, Díaz-Chamorro A, Olvera-Porcel C, Zamora M, Jiménez-Alonso J.

Lupus. 2015 Feb;24(2):155-63. doi: 10.1177/0961203314551811.

PMID:
25216653
10.

Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.

Vashi PG, Lammersfeld CA, Braun DP, Gupta D.

Nutr J. 2011 May 16;10:51. doi: 10.1186/1475-2891-10-51.

11.

Vitamin D deficiency in obese children and its relationship to glucose homeostasis.

Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR.

J Clin Endocrinol Metab. 2012 Jan;97(1):279-85. doi: 10.1210/jc.2011-1507.

12.

Prevalence of vitamin D insufficiency in obese children and adolescents.

Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S.

J Pediatr Endocrinol Metab. 2007 Jul;20(7):817-23.

PMID:
17849744
13.

Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Vilarrasa N, Vendrell J, Maravall J, Elío I, Solano E, San José P, García I, Virgili N, Soler J, Gómez JM.

Endocrine. 2010 Oct;38(2):235-42. doi: 10.1007/s12020-010-9379-4.

PMID:
21046484
14.

Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.

Belenchia AM, Tosh AK, Hillman LS, Peterson CA.

Am J Clin Nutr. 2013 Apr;97(4):774-81. doi: 10.3945/ajcn.112.050013.

15.

Insulin resistance indices are inversely associated with vitamin D binding protein concentrations.

Ashraf AP, Huisingh C, Alvarez JA, Wang X, Gower BA.

J Clin Endocrinol Metab. 2014 Jan;99(1):178-83. doi: 10.1210/jc.2013-2452.

16.

Hypovitaminosis D is independently associated with metabolic syndrome in obese patients.

Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A, Morini S, Leonetti F, Cavallo MG.

PLoS One. 2013 Jul 31;8(7):e68689. doi: 10.1371/journal.pone.0068689.

17.

Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis.

Goshayeshi L, Saber H, Sahebari M, Rezaieyazdi Z, Rafatpanah H, Esmaily H, Goshayeshi L.

Clin Rheumatol. 2012 Aug;31(8):1197-203. doi: 10.1007/s10067-012-1995-3.

PMID:
22581277
18.

Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study.

Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J.

Cardiovasc Diabetol. 2009 Feb 3;8:7. doi: 10.1186/1475-2840-8-7.

19.

Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE.

Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):577-83.

PMID:
17177140
20.

25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease.

Lee SY, Kim HY, Gu SW, Kim HJ, Yang DH.

Kidney Blood Press Res. 2012;35(5):349-54. doi: 10.1159/000335952.

Supplemental Content

Support Center